PTSM: Pharmaceutical Technology Sourcing and Management, Mar 6, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Mar 6, 2013
APIs
The Weaknesses and Strengths of the Global API Market
By Patricia Van Arnum
Supply-demand fundamentals show strong growth for generic APIs as gains in innovator APIs lag.
Contract Manufacturing
Fine-Chemical Producers Outline Expansion Plans at Informex
By Patricia Van Arnum
Contract API manufacturers and fine-chemical producers proceed with select investment in capacity and service additions.
Outsourcing
End of the Dedicated CMO?
By Jim Miller
Is the contract-only CMO an endangered species?
CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry Outlines Opportunity for Incremental Innovation to Improve Global Health
By Patricia Van Arnum
Incremental innovation advances medicines by expanding therapeutic classes, increasing the number of available dosing options, discovering new physiological interactions of known medicines, and improving other properties of existing medicines

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here